Tech Company Financing Transactions
Lipidio Pharmaceuticals Funding Round
Lipidio Pharmaceuticals, based in San Diego, secured investment capital from Foundation for Prader-Willi Research and private investors.
Transaction Overview
Company Name
Announced On
3/5/2020
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Foundation for Prader-Willi Research (John Walter)
Proceeds Purpose
The Series A financing, which will enable us to transition our lead program, GDD3898, into proof-of-concept clinical studies for new indications associated with excess body fat.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3570 Carmel Mountain Rd. 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
At Lipidio, patients remain at the center of all that we do. We are focused on and passionate about bringing the very best medicines to market to help patients in need. To do this, we leverage our teams' proven drug development track record to identify, develop and transform molecules into important medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gordon Foulkes
Chief Financial Officer
Gary Atkinson
Chief Operating Officer
Raksha Shah
Chief Scientific Officer
David Bullough
VP - Bus. Development
Jay Birnbaum
Browse more venture capital transactions:
Prev: 3/5/2020: Netlify venture capital transaction
Next: 3/5/2020: Reserved.AI venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs